Evidence map›Paper›PMID 41908668›Full record

ReviewRSC medicinal chemistry2026

Adamantane-based inhibitors of the influenza A M2 proton channel: structure-based design, biological evaluation, and synthetic approaches.

Marianna Stampolaki, Maria-Eleni Kouridaki, Kyriakos Georgiou, Antonios Kolocouris

Abstract readReview
In one paragraph

Review in RSC medicinal chemistry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Marianna StampolakiLaboratory of Medicinal Chemistry, Section of Pharmaceutical Chemistry, Department of Pharmacy, National and Kapodistrian University of Athens Panepistimiopolis-Zografou Athens 15771 Greece ankol@pharm.uoa.gr.ORCID https://orcid.org/0000-0002-0144-4792
Maria-Eleni KouridakiLaboratory of Medicinal Chemistry, Section of Pharmaceutical Chemistry, Department of Pharmacy, National and Kapodistrian University of Athens Panepistimiopolis-Zografou Athens 15771 Greece ankol@pharm.uoa.gr.
Kyriakos GeorgiouLaboratory of Medicinal Chemistry, Section of Pharmaceutical Chemistry, Department of Pharmacy, National and Kapodistrian University of Athens Panepistimiopolis-Zografou Athens 15771 Greece ankol@pharm.uoa.gr.
Antonios KolocourisLaboratory of Medicinal Chemistry, Section of Pharmaceutical Chemistry, Department of Pharmacy, National and Kapodistrian University of Athens Panepistimiopolis-Zografou Athens 15771 Greece ankol@pharm.uoa.gr.ORCID https://orcid.org/0000-0001-6110-1903

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The influenza A matrix 2 (AM2) protein, a prototype of viroporins, conducts protons along a chain of water molecules and ionizable side chains, including histidine-37. Solid-state NMR (ssNMR) and high-resolution X-ray crystal structures have been obtained for AM2 wild-type (WT) constructs in complex with adamantanamines, as well as for mutant AM2 channels that confer resistance to amantadine and adamantanamines across different pH levels. For the structure of AM2 S31N channels in complex with second-generation adamantane derivatives, consisting of an amantadine analog linked to an aryl group

Identifiers

PMID41908668
PMCPMC13020761

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.